Autonomy kicked off with tiny bits of information, a global insurance company is licensing its Intelligent Data Operating Layer (Idol) software. We don't know which, but we do know how much, the agreement is expected to be worth around $20m over the next few years.
A staggering amount really, but in the world of Autonomy, not unusual for a single contract as was demonstrated two and three days later when it made two even leaner announcements concerning two seven figure sum contracts, the first with a global media organisation, the second a US law firm, both to licence Idol.
Having announced a host of actual and potential new Chinese orders for its lighting technology last week, wireless lighting firm, Cyan, says it has received a new order for 50,000 units of its legacy product and has an order backlog that could see H2 2011 produce more revenues than the whole of 2009 and 2010 combined.
Kenn Lamb CEO of Cyan said the revenues and backlog halfway through the year represent the tip of the anticipated growth curve and bookings in H2 2011 are expected to be stronger than those in the first half.
The company did not release details of where or what the new order is for, but did say it now has a substantial order backlog accumulated during the first half of 2011 and if delivered within the current financial year, the revenues for H2 2011 would be double H1 and in excess of the full year revenues from 2009 and 2010, which totalled just over £250k.
He added that the orders are only the beginning of customers' actual requirements as they prefer to order at the rate of installation, rather than make a single upfront request for the entire project.
Brady, which again featured last week, announced an expanded contract for its Energy Solution with one of its key clients, referred to only as one of the world's largest producers and suppliers of oil and gas based in Scandinavia.
Brady produces commodity trading software tools. Following trials, the unnamed client will be employing the extended product for scheduling in the Netherlands and Germany, says Brady.
Half way through the financial year for many, Xaar, Aveva and Sagentia all provided positive interim trading updates with Xaar and Sagentia announcing H1 revenues would be ahead of board expectations, prompting an 11.9 per cent share price rise in the latter and an 8 per cent gain in the former.
Technology consultancy, Sagentia, was the pick of the bunch with an 11.9 per cent gain, up 9.25p to 86.75p a share as revenue for the period showed growth in excess of 20 per cent compared to the first half of 2010.
The company said the medical sector had been particularly resilient, the industrial sector less so, but with high utilisation, tight cost control and a lower risk (primarily time-and-materials) consultancy operating model now established, operating margin continued to improve.
Inkjet firm, Xaar, had a big 8.0 per cent improvement, up 21.8p to £2.95 a share after declaring H1 revenues would be ahead of expectations, up at least 30 per cent on 2010 H1 figures and in excess of Â£31m.
The company said sales of Platform 3 products (which are still capacity constrained), were stronger than expected due to both productivity gains and the impact of the early stages of the capacity ramp programme.
Cad specialist, Aveva, said it continued on its growth curve and that the company continued to be cash generative with a strong balance sheet as it pumps investment into its web solution, Aveva Net, and a focus on the development of the business in high growth Bric countries.blog comments powered by Disqus